Academic Center for Education, Culture and Research

The Academic Center for Education, Culture and Research (ACECR) (Persian: جهاد دانشگاهی‎‎) is an Iranian public non-governmental higher education institution established in 1980.

Mission

ACECR engages in innovative research and development projects in different fields of science and technology and real-world applications; for example in 2015 researchers led by Keyvan Majdzadeh produced a new formulation of anti-breast cancer drug Herceptin using a bacterial method.^[1] Its activities can be broadly divided into the areas of: research and technology, education, cultural activities, and entrepreneurship.

The scientific sectors it examines include: the petroleum industry, rail transport, biotechnology, power generation, and renewable energy.

Funding

Only 20% of ACECR's funding comes from public sources, while the majority of its funding is derived from partnerships and cooperation with the private sector.^[2]

Staffing

ACECR has 680 full-time research and academic staff, and 1,600 full-time research assistants.^[2] Its activities are supported by 2,100 services and administrative staff. Industry experts and post graduate research students also contribute to projects on a part-time basis.

References

External links

• Academic Center for Education, Culture and Research
• Avicenna Research Institute
• Royan Institute
• University of Science and Culture
• ACECR, Sharif University Branch